Global Big Data Conference

Artificial intelligence has remained a super-hot category for good reason: It has the potential to transform nearly every industry and business. At Insight, we've long been bullish on the many use cases for AI. In the past year, we've invested in image recognition software from Netherlands-based ScreenPoint Medical, which improves early detections of breast cancer, Covera Health, which provides a quality analytics platform to reduce medical errors in radiology, CARTO, which helps companies use and understand spatial analytics, and Laminar, a cloud data security platform to continuously monitor and protect against data leaks – among other game-changing companies. In total, Insight invested in 49 different companies across a broad spectrum of artificial intelligence and machine learning use cases in 2021, which represents a 172% increase from the year prior. As we look ahead into 2022, we expect artificial intelligence tools to continue to dominate.